This might lead to stronger signaling and subsequently higher IL-1β release and in agreement with previous reports on increased CaSR expression in patients with RA, which then was associated with heightened cardiovascular morbidity and mortality (Paccou et al., 2014). Here, CASR is linked to rheumatoid arthritis.